Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Cantor Fitzgerald
Dow
US Army
Johnson and Johnson
Farmers Insurance
Mallinckrodt
Boehringer Ingelheim
McKesson

Generated: October 22, 2017

DrugPatentWatch Database Preview

Sodium chromate cr-51 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sodium chromate cr-51 and what is the scope of sodium chromate cr-51 freedom to operate?

Sodium chromate cr-51
is the generic ingredient in two branded drugs marketed by Mallinkrodt Nuclear and Bracco, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred drug master file entries for sodium chromate cr-51.

Summary for Generic Name: sodium chromate cr-51

US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: see list1400
Clinical Trials: see list2,403
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sodium chromate cr-51 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
CHROMITOPE SODIUM
sodium chromate cr-51
INJECTABLE;INJECTION013993-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bracco
CHROMITOPE SODIUM
sodium chromate cr-51
INJECTABLE;INJECTION013993-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM CHROMATE CR 51
sodium chromate cr-51
INJECTABLE;INJECTION016708-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Deloitte
Dow
Boehringer Ingelheim
Queensland Health
Novartis
Cantor Fitzgerald
Harvard Business School
Cerilliant
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot